Zhengli Di

750 total citations
22 papers, 549 citations indexed

About

Zhengli Di is a scholar working on Molecular Biology, Neurology and Immunology. According to data from OpenAlex, Zhengli Di has authored 22 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Neurology and 6 papers in Immunology. Recurrent topics in Zhengli Di's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Extracellular vesicles in disease (3 papers). Zhengli Di is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (4 papers) and Extracellular vesicles in disease (3 papers). Zhengli Di collaborates with scholars based in China, Taiwan and United States. Zhengli Di's co-authors include Zhiqin Liu, Qianfa Long, Jianying Li, Panpan Xian, Tian Wang, Junle Yang, Shengxi Wu, Andrius Baskys, Rui Wang and Yue Hei and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Zhengli Di

21 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengli Di China 11 346 190 94 69 62 22 549
Xinhong Su China 9 359 1.0× 199 1.0× 119 1.3× 52 0.8× 62 1.0× 17 572
Xiaofei Ji China 9 214 0.6× 88 0.5× 101 1.1× 46 0.7× 56 0.9× 24 471
Mengtian Guo China 10 350 1.0× 175 0.9× 80 0.9× 29 0.4× 30 0.5× 14 480
Ya Lv China 10 307 0.9× 175 0.9× 127 1.4× 23 0.3× 43 0.7× 13 568
Xiaoyang Lu China 12 234 0.7× 127 0.7× 73 0.8× 60 0.9× 39 0.6× 21 531
Baoyan Fan United States 10 332 1.0× 192 1.0× 50 0.5× 82 1.2× 30 0.5× 18 521
Yanjie Jia China 13 230 0.7× 117 0.6× 67 0.7× 74 1.1× 29 0.5× 20 404
Fengshou Chen China 15 414 1.2× 331 1.7× 89 0.9× 21 0.3× 84 1.4× 29 673
Ming Huang China 14 276 0.8× 82 0.4× 162 1.7× 49 0.7× 28 0.5× 24 555
Jianhua Su China 12 282 0.8× 181 1.0× 55 0.6× 67 1.0× 36 0.6× 32 536

Countries citing papers authored by Zhengli Di

Since Specialization
Citations

This map shows the geographic impact of Zhengli Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengli Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengli Di more than expected).

Fields of papers citing papers by Zhengli Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengli Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengli Di. The network helps show where Zhengli Di may publish in the future.

Co-authorship network of co-authors of Zhengli Di

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengli Di. A scholar is included among the top collaborators of Zhengli Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengli Di. Zhengli Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Yue, Zhiqin Liu, Lele Deng, et al.. (2024). FGF21 attenuates neuroinflammation following subarachnoid hemorrhage through promoting mitophagy and inhibiting the cGAS-STING pathway. Journal of Translational Medicine. 22(1). 436–436. 18 indexed citations
4.
Chang, Le, et al.. (2021). An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection. Medicine. 100(5). e24451–e24451. 2 indexed citations
5.
Wei, Ming, et al.. (2021). miR‑497/MIR497HG inhibits glioma cell proliferation by targeting CCNE1 and the miR‑588/TUSC1 axis. Oncology Reports. 46(6). 8 indexed citations
6.
Liu, Zhiqin, Junlong Zhao, Jian Zang, et al.. (2020). MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7. Scientific Reports. 10(1). 4155–4155. 14 indexed citations
7.
Du, Jingjing, et al.. (2019). The Cannabinoid WIN 55,212-2 Reduces Delayed Neurologic Sequelae After Carbon Monoxide Poisoning by Promoting Microglial M2 Polarization Through ST2 Signaling. Journal of Molecular Neuroscience. 70(3). 422–432. 10 indexed citations
8.
Xian, Panpan, Yue Hei, Rui Wang, et al.. (2019). Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 9(20). 5956–5975. 277 indexed citations
9.
Gu, Naibing, Jun Wang, Zhengli Di, et al.. (2019). The Effects of Intelectin-1 on Antioxidant and Angiogenesis in HUVECs Exposed to Oxygen Glucose Deprivation. Frontiers in Neurology. 10. 383–383. 19 indexed citations
11.
Liu, Zhiqin, Jingjing Du, Zhiyong Zhang, et al.. (2018). miR-183-96-182 clusters alleviated ox-LDL-induced vascular endothelial cell apoptosis in vitro by targeting FOXO1. RSC Advances. 8(61). 35031–35041. 5 indexed citations
12.
Chang, Mingze, Lin Qiao, Bin Li, et al.. (2017). Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance. Oncology Reports. 38(2). 1251–1258. 40 indexed citations
13.
Gu, Naibing, Yaru Dong, Ye Tian, et al.. (2016). Anti-apoptotic and angiogenic effects of intelectin-1 in rat cerebral ischemia. Brain Research Bulletin. 130. 27–35. 26 indexed citations
14.
Chang, Mingze, Bei Zhang, Ye Tian, et al.. (2016). AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs’ Dysfunction and Strengthened Anti-oxidant Capacity. Inflammation. 40(2). 473–485. 18 indexed citations
15.
Cao, Lei, et al.. (2015). Down-Regulation of Homer1b/c Protects Against Chemically Induced Seizures Through Inhibition of mTOR Signaling. Cellular Physiology and Biochemistry. 35(4). 1633–1642. 13 indexed citations
16.
Gu, Naibing, et al.. (2014). Anti-inflammatory and Antiapoptotic Effects of Mesenchymal Stem Cells Transplantation in Rat Brain with Cerebral Ischemia. Journal of Stroke and Cerebrovascular Diseases. 23(10). 2598–2606. 37 indexed citations
17.
Tian, Ye, Bin Li, Wenzhen Shi, et al.. (2014). Dynamin-Related Protein 1 Inhibitors Protect against Ischemic Toxicity through Attenuating Mitochondrial Ca2+ Uptake from Endoplasmic Reticulum Store in PC12 Cells. International Journal of Molecular Sciences. 15(2). 3172–3185. 12 indexed citations
18.
Gu, Naibing, et al.. (2012). Shuanghuanglian injection downregulates nuclear factor-kappa B expression in mice with viral encephalitis.. PubMed. 7(33). 2592–9. 6 indexed citations
19.
Tian, Ye, et al.. (2011). Inhibitory effects of Shuanghuanglian injection on nuclear factor-kappa B expression in mice with viral encephalitis in a time- and dose-dependent manner. 6(24). 1865. 1 indexed citations
20.
Di, Zhengli, et al.. (2005). [Effect of endothelin-1 stimulation on peroxisome proliferator-activated receptor-gamma expression in vascular smooth muscle cells].. PubMed. 25(9). 1140–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026